학술논문
1387P - Differences in multikinase inhibitors (MKI) toxicity profile according to gender. A pooled analysis of three phase II trials with lenvatinib, pazopanib and sorafenib in patients (pts) with advanced gastroenteropancreatic (GEP) neuroendocrine tumours (NETs)
Document Type
Abstract
Author
Hernando Cubero, J. ; Grande, E. ; Castellano Gauna, D. ; Ibrahim, T. ; Fazio, N. ; Lopez, C. ; Teulé, A. ; Valle, J.W. ; Alonso, V. ; Molina-Cerrillo, J. ; Tafuto, S. ; Custodio, A. ; Trejo, L. ; Casteras, A. ; Manneh Kopp, R. ; Miqueo, C. ; Roca Herrera, M. ; Garcia-Carbonero, R. ; Salazar, R. ; Capdevila, J.
Source
In Annals of Oncology October 2019 30 Supplement 5:v567-v567
Subject
Language
ISSN
0923-7534